Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches

Recruiting N/A Interventional Study
Advanced or Metastatic Cancer Fear of Cancer Progression Metacognition-based Intervention Supportive-expressive Based Intervention Psychooncology
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
284 (estimated)
Sponsor
The University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (i.e. stage III or IV) cancer * are the age of 18 years or above Exclusion Criteria: * Patients with major communication difficulties * are being unwilling or unable to commit 6 p…
Contacts

Danielle Wing Lam Ng, PhD

+852 39179897

dwlng@hku.hk

CONTACT